New York’s West Texas Intermediate Crude Oil (WTI) ended above $73 overnight as investors eased concerns about the impact of the coronavirus. Omicron species After progress was reported on vaccines and drugs to treat COVID-19.
The WTI crude oil contract was delivered in February. It was up $1.03, or 1.4%, at $73.79 a barrel.
The Brent crude oil contract (BRENT) delivered in Feb. It was up $1.56, or 2.1%, at $76.85 a barrel.
WTI crude futures ended in positive territory for a third straight day on Wednesday amid confidence the omikron virus will not affect the economy and oil demand. After positive reports of COVID-19 vaccines and drugs Most recently, AstraZeneca stated that The company’s booster vaccine is effective against COVID-19. Omicron species Meanwhile, lab findings also indicate that AstraZeneca’s antibody cocktail, Evusheld, has been found to be more effective at preventing oxidative stress. able to neutralize the effects of the Omicron virus
The US Food and Drug Administration (FDA) has approved molnupiravir. Merck’s (Molnupiravir) It was the first drug to treat COVID-19 patients yesterday, the second drug approved for the United States to treat coronavirus after the FDA recently approved Fire company Paxlovid. Sir on Wednesday
Clinical trial results showed that Merck’s molnupiravir reduced the risk of hospitalization or death by approximately 30% when trialing the drug to unvaccinated people and There is a high risk of severe illness or death. While Pfizer stated Paxlovid could reduce the risk of COVID-19 patients in almost 90% of hospitalizations or deaths, as well as being effective in treating patients infected with the COVID-19 virus. Omicron species
This is the first time that oral medications and medications that patients can use at home are available. Approved for the treatment of COVID-19 The drug is thought to be a new tool used in the fight against the rapidly spreading Omicron strain.
- New York oil markets will be closed on Friday Dec 24 for the Christmas season.
.
